Sang Hee Lee

Dr. Sang Hee Lee

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2018 in Organic Letters
Verified
Journal Article
Closed access
SLSoobin Lim
Soobin Lim
DSDalnim Song
Dalnim Song
SJSeungwon Jeon
Seungwon Jeon
YKYoungsuk Kim
Youngsuk Kim
HKHyunseok Kim
Hyunseok Kim
ELEunsung Lee
Eunsung Lee

10 February 2020 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
NKNam-Young Kang
Nam-Young Kang
JLJung Yeol Lee
Jung Yeol Lee
SLSang Hee Lee
Sang Hee Lee
ISIn Ho Song
In Ho Song
YHYong Hwa Hwang
Yong Hwa Hwang
YCYoung-Tae Chang
Young-Tae Chang

3 October 2013 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
GPGinam Park
Ginam Park
SLSang Hee Lee
Sang Hee Lee
SSSang Jun Son
Sang Jun Son
SSSeunghoon Shin
Seunghoon Shin
Silica nanotubes (SNTs) functionalized with Pd-NPs on the inner surface performed as efficient nano-reactors for C–C coupling in water; the nano-confinement offers minimized leaching of Pd and yet efficient mass transfer for Suzuki–Miyaura coupling and C–H arylation of thiazoles in water with very high TON.

1 January 2020 in Theranostics
Verified
Journal Article
Open access
KKKyungmin Kim
Kyungmin Kim
HKHa Kim
Ha Kim
SBSung-Hwan Bae
Sung-Hwan Bae
SLSeok-Yong Lee
Seok-Yong Lee
YKYoung-Hwa Kim
Young-Hwa Kim
Hyewon YounHyewon Youn
Hyewon Youn
The 18 kDa translocator protein (TSPO) has been proposed as a biomarker for the detection of neuroinflammation. Although various PET probes targeting TSPO have been developed, a highly selective probe for detecting TSPO is still needed because single nucleotide polymorphisms in the human TSPO gene greatly affect the binding affinity of TSPO ligands. Here, we describe the visualization of neuroinflammation with a multimodality imaging system using our recently developed TSPO-targeting radionuclide PET probe [18F]CB251, which is less affected by TSPO polymorphisms.

1 January 2013 in Annals of Rehabilitation Medicine
Verified
Journal Article
Open access
PDF file
SPSee-Hyun Park
See-Hyun Park
SPSung-Hee Park
Sung-Hee Park
SLSang Hee Lee
Sang Hee Lee
Park SH, et al. Ann Rehabil Med. 2013 Oct;37(5):713-716. http://dx.doi.org/10.5535/arm.2013.37.5.713

29 May 2021 in Cells
Verified
Journal Article
Open access
PDF file
YSYoo Sung Song
Yoo Sung Song
SLSang Hee Lee
Sang Hee Lee
JJJae Ho Jung
Jae Ho Jung
ISIn Ho Song
In Ho Song
HPHyun Soo Park
Hyun Soo Park
BLByung Chul Lee
Byung Chul Lee
We performed in vivo PET imaging with 3-[18F]F-CP118,954 (1) for acetylcholinesterase (AChE) and [18F]fluoromethyl-PBR28-d2 (2) for translocator protein 18-kDa (TSPO) to investigate the inflammatory brain response after stroke. Imaging studies were performed in the middle cerebral artery occlusion (MCAO) Sprague-Dawley rat model for a period of three weeks. The percentage injected dose per tissue weight (%ID/g) of striatum of 1, and cortex of 2 were obtained, respectively. To trace the sequential inflammatory responses, AChE imaging of 1 was done on post-MCAO day 2, after giving cold PK-11195 for 1 day, and TSPO imaging of 2 was carried out on post-MCAO day 11, after giving donepezil for 10 days. AChE activity in the MCAO-lesioned side were significantly higher than that of the contralateral side on day one, and TSPO activity was highest on day 11. TSPO inhibitor, PK-11195 did not affect AChE activity on day two, while AChE inhibitor, donepezil significantly lowered TSPO binding on day 12. Our study demonstrates that AChE level is elevated in the early course of brain ischemia as a trigger for the inflammatory response, and TSPO level is elevated persistently throughout the post-ischemic injury in the brain. Also, the AChE inhibitor may be able to inhibit or delay neurotoxic inflammatory responses and serve as a beneficial treatment option.